Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review

Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review, a practical, business-focused analysis of recent changes and developments, their effects, and a look forward at expected trends in the sector. ​

In this chapter, the authors first briefly present the general Belgian legislative and regulatory framework and examine a series of domestic peculiarities for new drugs, generics, biologics and biosimilars. Next, the interfaces between the pharmaceutical sector and patent law are analysed. To conclude, the authors focus on the interfaces between the pharmaceutical sector and competition law. In this regard, an overview of the competition enforcers, their role in merger control and approach to anticompetitive behaviours in the pharmaceutical sector is provided.

Click here for an overview of the Review's content​, and here to read the Belgian chapter​.​

Reproduced with permission from Law Business Research Ltd
This article was first published in September 2020.